Vemurafenib: Result unchanged despite new data

Wednesday, December 18, 2013 - 22:00 in Health & Medicine

The manufacturer's second dossier on the drug Vemurafenib contained additional and more recent data, but did not provide any new findings. Hence the result "indication of considerable added benefit" remains unchanged.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net